BionicM Inc.
PrivateLast Round
Series B
Nov 2, 2026
Total Funding Raised
$12.53M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
BionicM Inc. operates in Healthcare & Life Sciences and is based in Tokyo. Its latest recorded funding round was a Series B round in November 2026.
BionicM Inc. is a medical devices company that develops and markets powered robotic prosthetics to improve the quality of life for lower-limb amputees.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Industrial Robotics, Health IoT
Business Model
B2B2C
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BionicM Inc. Comparables
Compare BionicM Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BrainCo Inc. | 79% | |
| WillowWood Global | 76% | |
| Otto Bock | 76% |
For institutional investors. Book with your work email.
BionicM Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Nov 2, 2026 | ||||
| VC Round | Oct 8, 2024 | ||||
| Series A Extension | Jan 31, 2023 | ||||
| Series A | Aug 1, 2020 | ||||
| Seed | Mar 18, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
BionicM Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SBI Shinsei Corporate Investment | Series A Extension |
| B Dash Ventures | Series B |
| UTEC (The University of Tokyo Edge Capital Partners) | VC Round, Series A Extension, Seed, Series A |
| Chibagin Capital | Series A Extension |
| Kiraboshi Capital Co., Ltd. | Series A Extension |
| NVenture Capital Co., Ltd. | Series A Extension |
| Mitsubishi UFJ Capital | Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 2, 2026
$4.5M round led by Mitsubishi UFJ Capital and B Dash Ventures.
- Aug 21, 2026
Monthly visitors grew 161% MoM, reaching 8K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- receives_financingNov 10, 2026
BionicM Inc. receives $4.25M in Series B financing in Japan on Nov 10th '26, with B Dash Ventures and Mitsubishi UFJ Capital participating, to reinforce production infrastructure and expand U.S. sales and marketing ahead of the planned 2027 commercial launch of ASISTA.
- receives_financingNov 5, 2026
BionicM Inc. says its total raised reaches $19.8M, including equity and grants, after a $5.46 million first close of its Series B round funds production, marketing, and sales for its Asista powered prosthetic knee.
- receives_financingNov 5, 2026
BionicM Inc. receives $5.46M in a first close of its Series B round to fund production, marketing, and sales for its Asista MPK.
For institutional investors. Book with your work email.
BionicM Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about BionicM Inc.'s valuation, stock price, and market status.
Is BionicM Inc. a public or private company?
BionicM Inc. is a private company.
What is the current stock price of BionicM Inc.?
BionicM Inc. is a private company, so its shares have no public market price. Caplight tracks BionicM Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BionicM Inc. worth (valuation)?
Valuation information for BionicM Inc. is not publicly available.
Can I buy BionicM Inc. stock?
BionicM Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BionicM Inc.'s last funding round?
BionicM Inc.'s most recent funding round was Series B on November 2, 2026.
Who are the main investors in BionicM Inc.?
Key investors in BionicM Inc. include B Dash Ventures, UTEC (The University of Tokyo Edge Capital Partners), NVenture Capital Co., Ltd., Mitsubishi UFJ Capital.
Will BionicM Inc. IPO soon?
No public IPO plans have been announced for BionicM Inc..
How can I track BionicM Inc. secondary market activity?
Caplight tracks bids, offers, and trades in BionicM Inc.'s shares on secondary markets.